LINC01133: A Drug Target / Disease Biomarker (G100505633)

Target Name: LINC01133

NCBI ID: G100505633

LINC01133

Other Name(s): long intergenic non-protein coding RNA 1133 | Long intergenic non-protein coding RNA 1133

LINC01133: A Drug Target / Disease Biomarker

LINC01133 is a protein that is expressed in various tissues throughout the body, including the brain, heart, liver, and kidneys. It is a key regulator of the cell cycle, which means it helps keep cells dividing and growing in a controlled and orderly manner. LINC01133 is also involved in the development and maintenance of tissues, including the placenta and the immune system.

One of the most promising aspects of LINC01133 is its potential as a drug target. Researchers have identified several potential drug targets for LINC01133, including those that interact with the protein in different ways. These drug targets include the alpha-tubulin protein, which is a key component of the cytoskeleton, as well as the p53 protein, which is a well-known tumor suppressor gene.

In addition to its potential as a drug target, LINC01133 has also been identified as a potential biomarker. This is because the levels of LINC01133 are regulated by a variety of factors, including the cell cycle, which is a key factor in the development and progression of many diseases. As a result, changes in the levels of LINC01133 may be an important indicator of the health of a cell or the presence of a particular disease.

Research into LINC01133 as a drug target and biomarker is still in its early stages, but it has the potential to be a valuable tool for the development of new treatments for a variety of diseases. As more research is conducted, it is likely that we will gain a better understanding of the role of LINC01133 in these processes and the potential benefits and risks of targeting it as a drug or biomarker.

Overall, LINC01133 is a protein that has the potential to be a drug target or biomarker, and further research is needed to fully understand its role in these processes.

Protein Name: Long Intergenic Non-protein Coding RNA 1133

The "LINC01133 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01133 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets